Domestic firms’ strategic alliance with multinational firms bring no benefits

Published: 2012-09-26 07:00:00

Updated: 2012-09-26 07:00:00

A number of domestic pharmaceutical firms already established strategic alliances with multinational firms here, in a desperate efforts to boost sales to soften the hardest impacts caused by the govement-mandated cuts in drug price, but their margin profits seem to be negligible, a market source ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK